FROM KNOWLEDGE TO SOLUTIONS
Where scientific rigor meets real-world healthcare impact
InnoValHC is an independent research institute combining scientific excellence, senior academic and industry expertise, and a trusted international expert network. We help you successfully navigate the most demanding challenges in health economics, HTA, value assessment, pricing, reimbursement, and patient access strategy.
Contact us to find out how we can best support you to convert complexity into evidence, value, and access.
Access to Rare and Complex Disease Therapies
Michael Schlander gave a presentation at the European Parliament in Brussels, Belgium, as part of the ´Health Leadership Mission for Rare Diseases´ (HLM4Rare) platform (July 01, 2026).
Heidelberg Health Economics Summer School 2026
The Heidelberg Health Economics Summer School Basic Module took place in the picturesque setting of the Italian Dolomites (Bruneck-Brunico, June 25-27, 2026).
German Cancer Congress (DKK) 2026
Michael Schlander was invited to contribute to the Highlight Session ´Socioeconomic Consequences of Cancer in Germany: The Perspective of Patients and their Relatives´ at the DKK in Berlin / Germany (Feb. 21, 2026).
Financing Health Care: Structural Challenges in Germany
Article published by Michael Schlander on structural challenges in health care financing and necessary reforms in the German health care system.
Read more … Financing Health Care: Structural Challenges in Germany
Advancing Health Economics with Scientific Integrity
We believe that health economics should serve as a bridge between medical innovation and sustainable, value-based, patient-centered healthcare systems. As an independent, highly specialized advisory team, we maintain strict scientific credibility while delivering high-impact solutions. We reject the rigid, one-size-fits-all models of traditional value analyses and instead provide objective, evidence-based insights that serve both private life science companies, public research organizations, and healthcare policy makers.
Our research service offers are designed to support our partners at every stage of the research, regulatory, and patient access challenges. Whether we are building advanced economic models for commercial therapies, delivering executive education, or participating in large European research consortia as a trusted health economics partner, our work is always anchored in scientific rigor and transparent methodology. Explore our core pillars below to see how rigorous science meets our commitment to improving patient lives and shaping a fairer healthcare system.